...
search icon
prax-img

Praxis Precision Medicines Inc, Common Stock

PRAX

NSQ

$33.79

+$3.96

(13.28%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$599.66M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
0
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
2.68
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$26.7 L
$91.83 H
$33.79

About Praxis Precision Medicines Inc, Common Stock

Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapies for central nervous system disorders characterized by neuronal excitation-inhibition imbalance. The company offers cerebrum, a small molecule platform for CNS small molecule therapies and solidus, an antisense oligonucleotide platform to discover and develop antisense oligonucleotide. It is developing ulixacaltamide, a small molecule inhibitor of T-type calcium channels that is in Phase III clinical trial for the treatment of essential tremor; vormatrigine, a small molecule targeting the hyperexcitable state of sodium-channels in the brain to treat focal onset epilepsy; relutrigine for the treatment of developmental and epileptic encephalopathies; PRAX-020; and PRAX-050. In addition, the company develops elsunersen, a clinical-stage ASO designed to regulate NaV1.2 expression for the treatment of SCN2A-DEE; PRAX-080; PRAX-090; and PRAX-100. It has a license agreement with RogCon Inc.; and research collaboration and license agreement with Ionis Pharmaceuticals, Inc. The company was incorporated in 2015 and is based in Boston, Massachusetts. more

Industry: BiotechnologySector: Health Care

Returns

Time FramePRAXSectorS&P500
1-Week Return18.69%0.44%0.24%
1-Month Return-13.2%-7.69%-7.32%
3-Month Return-52.1%-3.35%-12.05%
6-Month Return-54.9%-11.09%-9.73%
1-Year Return-33.46%-2.13%5.05%
3-Year Return-73.31%-1.18%20.03%
5-Year Return-91.9%34.44%83.31%

Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue--1.46M2.45M8.55M[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":17.12,"profit":true},{"date":"2023-12-31","value":28.61,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Cost of Revenue746.00K1.59M1.17M86.77M-[{"date":"2020-12-31","value":0.86,"profit":true},{"date":"2021-12-31","value":1.84,"profit":true},{"date":"2022-12-31","value":1.35,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Gross Profit(746.00K)(1.59M)(1.17M)2.45M8.55M[{"date":"2020-12-31","value":-8.72,"profit":false},{"date":"2021-12-31","value":-18.64,"profit":false},{"date":"2022-12-31","value":-13.69,"profit":false},{"date":"2023-12-31","value":28.61,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Margin--(79.99%)100.00%100.00%[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-79.99,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Expenses61.97M167.33M214.99M128.82M208.72M[{"date":"2020-12-31","value":28.82,"profit":true},{"date":"2021-12-31","value":77.83,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":59.92,"profit":true},{"date":"2024-12-31","value":97.08,"profit":true}]
Operating Income(61.97M)(167.33M)(214.99M)(126.37M)(200.16M)[{"date":"2020-12-31","value":-6196800000,"profit":false},{"date":"2021-12-31","value":-16733200000,"profit":false},{"date":"2022-12-31","value":-21498600000,"profit":false},{"date":"2023-12-31","value":-12637300000,"profit":false},{"date":"2024-12-31","value":-20016500000,"profit":false}]
Total Non-Operating Income/Expense280.00K----[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Pre-Tax Income(61.83M)(167.06M)(214.03M)(123.28M)(182.82M)[{"date":"2020-12-31","value":-6182800000,"profit":false},{"date":"2021-12-31","value":-16706100000,"profit":false},{"date":"2022-12-31","value":-21402900000,"profit":false},{"date":"2023-12-31","value":-12327700000,"profit":false},{"date":"2024-12-31","value":-18281900000,"profit":false}]
Income Taxes(8.00K)(182.00K)(957.00K)264.11K-[{"date":"2020-12-31","value":-3.03,"profit":false},{"date":"2021-12-31","value":-68.91,"profit":false},{"date":"2022-12-31","value":-362.36,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes(61.82M)----[{"date":"2020-12-31","value":-6182000000,"profit":false},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income From Continuous Operations(61.82M)(167.06M)(214.03M)(137.57M)(182.82M)[{"date":"2020-12-31","value":-6182000000,"profit":false},{"date":"2021-12-31","value":-16706100000,"profit":false},{"date":"2022-12-31","value":-21402900000,"profit":false},{"date":"2023-12-31","value":-13757200000,"profit":false},{"date":"2024-12-31","value":-18281900000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(61.82M)(166.88M)(213.07M)(123.28M)(182.82M)[{"date":"2020-12-31","value":-6182000000,"profit":false},{"date":"2021-12-31","value":-16687900000,"profit":false},{"date":"2022-12-31","value":-21307200000,"profit":false},{"date":"2023-12-31","value":-12327700000,"profit":false},{"date":"2024-12-31","value":-18281900000,"profit":false}]
EPS (Diluted)(16.87)(3.89)(4.66)(4.35)(10.27)[{"date":"2020-12-31","value":-1687,"profit":false},{"date":"2021-12-31","value":-389,"profit":false},{"date":"2022-12-31","value":-466,"profit":false},{"date":"2023-12-31","value":-435,"profit":false},{"date":"2024-12-31","value":-1027,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

PRAX
Cash Ratio 10.45
Current Ratio 10.77

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

PRAX
ROA (LTM) -43.82%
ROE (LTM) -70.98%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

PRAX
Debt Ratio Lower is generally better. Negative is bad. 0.08
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.92

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

PRAX
Trailing PE NM
Forward PE NM
P/S (TTM) 79.66
P/B 1.53
Price/FCF NM
EV/R 33.92
EV/Ebitda NM

FAQs

What is Praxis Precision Medicines Inc share price today?

Praxis Precision Medicines Inc (PRAX) share price today is $33.79

Can Indians buy Praxis Precision Medicines Inc shares?

Yes, Indians can buy shares of Praxis Precision Medicines Inc (PRAX) on Vested. To buy Praxis Precision Medicines Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in PRAX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Praxis Precision Medicines Inc be purchased?

Yes, you can purchase fractional shares of Praxis Precision Medicines Inc (PRAX) via the Vested app. You can start investing in Praxis Precision Medicines Inc (PRAX) with a minimum investment of $1.

How to invest in Praxis Precision Medicines Inc shares from India?

You can invest in shares of Praxis Precision Medicines Inc (PRAX) via Vested in three simple steps:

  • Click on Sign Up or Invest in PRAX stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Praxis Precision Medicines Inc shares
What is Praxis Precision Medicines Inc 52-week high and low stock price?

The 52-week high price of Praxis Precision Medicines Inc (PRAX) is $91.83. The 52-week low price of Praxis Precision Medicines Inc (PRAX) is $26.7.

What is Praxis Precision Medicines Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Praxis Precision Medicines Inc (PRAX) is 1.53

What is the Market Cap of Praxis Precision Medicines Inc?

The market capitalization of Praxis Precision Medicines Inc (PRAX) is $599.66M

What is Praxis Precision Medicines Inc’s stock symbol?

The stock symbol (or ticker) of Praxis Precision Medicines Inc is PRAX

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top